Health ministry questions reliability of vasculitis drug approval data

🇯🇵 Article en anglais

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Read the original article

Source : The Japan Times. Le Fil Indépendant cite et lie cet article ; il n'en est ni l'auteur ni l'éditeur.